Terms: = Kidney tumors AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Prognosis
17 results:
1. [Clinicopathologic features and prognosis of young renal tumors with tumor thrombus].
Xue ZX; Tang SY; Qiu M; Liu C; Tian XJ; Lu M; Dong JH; Ma LL; Zhang SD
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):802-811. PubMed ID: 37807732
[TBL] [Abstract] [Full Text] [Related]
2. Development of an Immune Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Tumor Microenvironment.
Wang M; Song Q; Song Z; Xie Y
Horm Metab Res; 2023 Jun; 55(6):402-412. PubMed ID: 37192644
[TBL] [Abstract] [Full Text] [Related]
3. Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study.
Zhang Y; Yi X; Tang Z; Xie P; Yin N; Deng Q; Zhu L; Luo H; Peng K
Front Public Health; 2023; 11():1104931. PubMed ID: 37033061
[TBL] [Abstract] [Full Text] [Related]
4. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Zaman S; Hajiran A; Coba GA; Robinson T; Madanayake TW; Segarra DT; Chobrutskiy BI; Boyle TA; Zhou JM; Kim Y; Mulé JJ; Teer JK; Manley BJ
Eur Urol Focus; 2021 Mar; 7(2):373-380. PubMed ID: 31901438
[TBL] [Abstract] [Full Text] [Related]
9. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W
J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
[TBL] [Abstract] [Full Text] [Related]
10. The Association of Androgen Receptor Expression with Renal Cell Carcinoma Risk: a Systematic Review and Meta-Analysis.
Yuan P; Ge Y; Liu X; Wang S; Ye Z; Xu H; Chen Z
Pathol Oncol Res; 2020 Apr; 26(2):605-614. PubMed ID: 30919276
[TBL] [Abstract] [Full Text] [Related]
11. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract] [Full Text] [Related]
12. Relationship Between Mortality and Cancer-Bearing Status at Time of Dialysis Initiation.
Tanaka A; Inaguma D; Shinjo H; Murata M; Takeda A
Ther Apher Dial; 2017 Aug; 21(4):345-353. PubMed ID: 28322029
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shen J; Chen Z; Zhuang Q; Fan M; Ding T; Lu H; He X
PLoS One; 2016; 11(11):e0166482. PubMed ID: 27861542
[TBL] [Abstract] [Full Text] [Related]
14. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract] [Full Text] [Related]
15. Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alpha.
Yang S; de Souza P; Alemao E; Purvis J
Br J Cancer; 2010 May; 102(10):1456-60. PubMed ID: 20461090
[TBL] [Abstract] [Full Text] [Related]
16. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
[TBL] [Abstract] [Full Text] [Related]
17. Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.
Negrier S; Perol D; Ravaud A; Chevreau C; Bay JO; Delva R; Sevin E; Caty A; Escudier B;
Cancer; 2007 Dec; 110(11):2468-77. PubMed ID: 17932908
[TBL] [Abstract] [Full Text] [Related]
